发明名称 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS
摘要 The instant invention provides compounds of Formula (I) which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
申请公布号 US2016272632(A1) 申请公布日期 2016.09.22
申请号 US201414778046 申请日期 2014.03.19
申请人 CHILDERS Matthew Lloyd;FULLER Peter;GUERIN David;KATZ Jason David;PU Qinglin;SCOTT Mark E.;THOMPSON Christopher E.;MARTINEZ Michelle;FALCONE Danielle;TORRES Luis;DENG Yongqi;KURUKULASURIYA Ravi;ZENG Hongbo;BAI Yunfeng;KONG Norman;LIU Yumei;MERCK SHARP & DOHME CORP. 发明人 Childers Matthew Lloyd;Fuller Peter;Guerin David;Katz Jason David;Pu Qinglin;Scott Mark E.;Thompson Christopher F.;Martinez Michelle;Falcone Danielle;Torres Luis;Deng Yongqi;Kurukulasuriya Ravi;Zeng Hongbo;Bai Yunfeng;Kong Norman;Liu Yumei;Zheng Zhixiang
分类号 C07D471/04;C07D519/00 主分类号 C07D471/04
代理机构 代理人
主权项 1. A compound of Formula I or a pharmaceutically acceptable salt, or a stereoisimer thereof: A is selected from aryl, heteroaryl, cycloalkylC(0-10)alkyl, C1-6alkyl; R2 and R3 are each independently selected from hydrogen, C1-4alkyl and hydroxy, wherein R2 and R3 may optionally, join together with the carbon they are attached to form a 3 to 6 membered ring; X1 is C; X2, X3, and X4 are each independently selected from O, N, S, and C and provided that the formed ring system contains 0, 1, 2, or 3 atoms selected from O, N and S; n is 0, 1, 2, 3 or 4; m is 0, 1, 2, 3 or 4; p is 0, 1, 2, 3, or 4; R4 is selected from: halogen,oxo (═O),C1-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C1-10 heteroalkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C2-10 alkenyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,aryl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C3-12 cycloalkyl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,heteroaryl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C0-10 alkyl(oxy)0-1 (carbonyl)0-1 aminoC0-10 alkyl,C1-10 alkylamino(carbonyl)0-1C0-10alkyl,(C1-10)heteroalkyl(oxy)0-1 (carbonyl)0-1 amino C0-10 alkyl,(C1-10)heteroalkylamino(carbonyl)0-1 C0-10alkyl,C3-12 cycloalkyl C0-10 alkylaminoC0-10 alkyl,aryl C0-10 alkylaminoC0-10 alkyl,heteroaryl C0-10 alkylaminoC0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkylaminoC0-10 alkyl,C1-10 alkylsulfonyl,C1-10 heteroalkylsulfonyl,(C3-12)cycloalkylC0-10alkylsulfonyl,(C3-12)cycloheteroalkylC0-10alkylsulfonyl,heteroarylC0-10 alkylsulfonyl,arylC0-10 alkylsulfonyl,—SO2NH2,—SO2NH(C1-6alkyl),—SO2N(C1-6alkyl)2,C0-10 alkylsulfamoyl,C1-10 heteroalkylsulfamoyl,(C3-12)cycloalkylC0-10 alkylsulfamoyl,(C3-12)cycloheteroalkylC0-10 alkylsulfamoyl,heteroarylC0-10 alkylsulfamoyl,arylC0-10 alkylsulfamoyl,C0-10 alkylsulfonimidoylC0-10 alkyl,C1-10 heteroalkylsulfonimidoylC0-10 alkyl,(C3-12)cycloalkylC0-10 alkylsulfonimidoylC0-10 alkyl,(C3-12)cycloheteroalkylC0-10alkylsulfonimidoylC0-10 alkyl,heteroarylC0-10 alkylsulfonimidoylC0-10 alkyl,arylC0-10 alkylsulfonimidoylC0-10 alkyl,(C1-10 alkyl)1-2amino,—CO2(C0-10 alkyl),—(C0-10 alkyl)CO2H,—SO2CF3,—SO2CF2H,—SO2CH2CF3,C1-10 alkylsulfinyl,C1-4acylaminoC0-10 alkyl,hydroxy,—(C1-10 alkyl)OH,C1-10 alkoxyC0-10 alkyl,cyano,(C1-6alkyl)cyano, andC1-6haloalkyl, wherein two R4 together with the ring atom to which each is attached optionally may form a saturated ring; R5 is selected from: halogen,oxo (═O),C1-10 alkyl(oxy)0-1 (carbonyl)0-1 C0-10 alkyl,C1-10 heteroalkyl(oxy)0-1 (carbonyl)0-1 C0-10 alkyl,C2-10 alkenyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,aryl C0-10 alkyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,C3-12 cycloalkyl C0-10 alkyl(oxy)0-1 (carbonyl)0-1 C0-10 alkyl,heteroaryl C0-10 alkyl(oxy)0-1 (carbonyl)0-1 C0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkyl(oxy)0-1 (carbonyl)0-1 C0-10 alkyl,C0-10 alkylaminocarbonylC0-1 alkyl,C0-10 alkyl(oxy)0-1 (carbonyl)0-1 aminoC0-10 alkyl,(C1-10)heteroalkyl(oxy)0-1(carbonyl)0-1 aminoC0-10 alkyl,C3-12 cycloalkyl C0-10 alkylaminoC0-10 alkyl,aryl C0-10 alkylaminoC0-10 alkyl,heteroaryl C0-10 alkylaminoC0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkylaminoC0-10 alkyl,(C1-10 alkyl)1-2 amino,—SF5,C0-10 alkylsulfonyl,C1-10 heteroalkylsulfonyl,(C3-12)cycloalkylC0-10alkylsulfonyl,(C3-12)cycloheteroalkylC0-10 alkylsulfonyl,heteroarylC0-10 alkylsulfonyl,arylC0-10 alkylsulfonyl,C0-10 alkylsulfamoyl,C1-10 heteroalkylsulfamoyl,(C3-12)cycloalkylC0-10 alkylsulfamoyl,(C3-12)cycloheteroalkylC0-10 alkylsulfamoyl,heteroarylC0-10 alkylsulfamoyl,C0-10 alkylsulfonimidoylC0-10 alkyl,C1-10 heteroalkylsulfonimidoylC0-10 alkyl,(C3-12)cycloalkylC0-10 alkylsulfonimidoylC0-10 alkyl,(C3-12)cycloheteroalkylC0-10alkylsulfonimidoylC0-10 alkyl,heteroarylC0-10 alkylsulfonimidoylC0-10 alkyl,arylC0-10 alkylsulfonimidoylC0-10 alkyl,—SO2NH2,—SO2NH(C1-6alkyl),—SO2N(C1-6alkyl)2,arylC0-10 alkylsulfamoyl,(C0-10 alkyl)1-2 amino,—CO2(C0-10 alkyl),—(C0-10 alkyl)CO2H,—SO2CF3,—SO2CF2H,—SO2CH2CF3,C1-10 alkylsulfinyl,C1-4acylaminoC0-10 alkyl,hydroxy,—(C1-10 alkyl)OH,C1-10 alkoxyC0-10 alkyl,cyano,(C1-6alkyl)cyano, andC1-6haloalkyl; and wherein R4 and R5 are each optionally substituted with 1, 2, 3, or 4 R6 substituents and R6 is independently selected from: halogen,C1-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C1-10 heteroalkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,C2-10 alkenyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,aryl C0-10 alkyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,C3-12 cycloalkyl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,heteroaryl C0-10 alkyl(oxy)0-1 (carbonyl)0-1C0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkyl(oxy)0-1(carbonyl)0-1C0-10 alkyl,C1-10 alkyl(carbonyl)0-1oxyC0-10 alkyl,C2-10 alkenyl(carbonyl)0-1 oxyC0-10 alkyl,C1-10 heteroalkyl(carbonyl)0-1 oxyC0-10 alkyl,aryl C0-10 alkyl (carbonyl)0-1oxyC0-10 alkyl,(C3-12)cycloalkyl C0-10 alkyl(carbonyl)0-1 oxyC0-10 alkyl,heteroarylC0-10 alkyl(carbonyl)0-1 oxyC0-10 alkyl,(C3-12)heterocycloalkyl C0-10 alkyl(carbonyl)0-1 oxyC0-10 alkyl,((C0-10)alkyl)1-2aminocarbonyloxy,aryl (C0-10)alkylaminocarbonyloxy,—CO2(C0-10 alkyl),—(C0-10 alkyl)CO2H,oxo (═O),C0-10 alkylsulfonyl,C1-10 heteroalkylsulfonyl,(C3-12) cycloalkylsulfonyl,(C3-12) cycloheteroalkylsulfonyl,heteroarylsulfonyl,arylsulfonyl,aminosulfonyl,—SO2NH2,—SO2NH(C1-6alkyl),—SO2N(C1-6alkyl)2,—SO2CF3,—SO2CF2H,C1-10 alkylsulfinyl,amino,(C1-10 alkyl)1-2amino,-(oxy)0-1 (carbonyl)0-1N(C0-10 alkyl)1-2 C1-4acylaminoC0-10 alkyl,hydroxy,(C1-10 alkyl)OH,C1-10 alkoxyC0-10 alkyl,(C1-10 alkyl)cyano,cyano, andC1-6haloalkyl; and R6 is optionally substituted with 1, 2, or 3 R7 substituents selected from hydrogen, hydroxy, (C1-6)alkyl, C1-10 alkoxyC0-10 alkyl, (C1-10 alkyl)OH, halogen, CO2H, —(C0-6)alkylCN, —O(C═O)C1-C6 alkyl, NO2, trifluoromethoxy, trifluoroethoxy, trifluoromethyl, trifluoroethyl, —N—C(O)O(C0-6)alkyl, C1-10 alkylsulfonyl, oxo (O═), aminosulfonyl, —SO2C1-6alkyl, —SO2CF3, —SO2CF2H, —C1-10 alkylsulfinyl, —O(0-1)(C1-10)halo, —SO2NH2, —SO2NH(C1-6alkyl), —SO2N(C1-6alkyl)2, alkyl, amino(C1-6alkyl)0-2 and NH2.
地址 Boston MA US